These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

479 related items for PubMed ID: 30756456

  • 1. Improving fiducial and prostate capsule visualization for radiotherapy planning using MRI.
    Pathmanathan AU, Schmidt MA, Brand DH, Kousi E, van As NJ, Tree AC.
    J Appl Clin Med Phys; 2019 Mar; 20(3):27-36. PubMed ID: 30756456
    [Abstract] [Full Text] [Related]

  • 2. Comparison of prostate delineation on multimodality imaging for MR-guided radiotherapy.
    Pathmanathan AU, McNair HA, Schmidt MA, Brand DH, Delacroix L, Eccles CL, Gordon A, Herbert T, van As NJ, Huddart RA, Tree AC.
    Br J Radiol; 2019 Mar; 92(1095):20180948. PubMed ID: 30676772
    [Abstract] [Full Text] [Related]

  • 3. Automatic Substitute Computed Tomography Generation and Contouring for Magnetic Resonance Imaging (MRI)-Alone External Beam Radiation Therapy From Standard MRI Sequences.
    Dowling JA, Sun J, Pichler P, Rivest-Hénault D, Ghose S, Richardson H, Wratten C, Martin J, Arm J, Best L, Chandra SS, Fripp J, Menk FW, Greer PB.
    Int J Radiat Oncol Biol Phys; 2015 Dec 01; 93(5):1144-53. PubMed ID: 26581150
    [Abstract] [Full Text] [Related]

  • 4. Using C-Arm X-ray images from marker insertion to confirm the gold fiducial marker identification in an MRI-only prostate radiotherapy workflow.
    Gustafsson C, Persson E, Gunnlaugsson A, Olsson LE.
    J Appl Clin Med Phys; 2018 Nov 01; 19(6):185-192. PubMed ID: 30354010
    [Abstract] [Full Text] [Related]

  • 5. Magnetic resonance imaging in the radiation treatment planning of localized prostate cancer using intra-prostatic fiducial markers for computed tomography co-registration.
    Parker CC, Damyanovich A, Haycocks T, Haider M, Bayley A, Catton CN.
    Radiother Oncol; 2003 Feb 01; 66(2):217-24. PubMed ID: 12648794
    [Abstract] [Full Text] [Related]

  • 6. Evaluation of gold fiducial marker manual localisation for magnetic resonance-only prostate radiotherapy.
    Maspero M, Seevinck PR, Willems NJW, Sikkes GG, de Kogel GJ, de Boer HCJ, van der Voort van Zyp JRN, van den Berg CAT.
    Radiat Oncol; 2018 Jun 05; 13(1):105. PubMed ID: 29871656
    [Abstract] [Full Text] [Related]

  • 7. Registration free automatic identification of gold fiducial markers in MRI target delineation images for prostate radiotherapy.
    Gustafsson C, Korhonen J, Persson E, Gunnlaugsson A, Nyholm T, Olsson LE.
    Med Phys; 2017 Nov 05; 44(11):5563-5574. PubMed ID: 28803447
    [Abstract] [Full Text] [Related]

  • 8. Accuracy of an MR-only workflow for prostate radiotherapy using semi-automatically burned-in fiducial markers.
    Goudschaal K, Beeksma F, Boon M, Bijveld M, Visser J, Hinnen K, van Kesteren Z.
    Radiat Oncol; 2021 Feb 19; 16(1):37. PubMed ID: 33608008
    [Abstract] [Full Text] [Related]

  • 9. Fiducial marker for prostate radiotherapy: comparison of 0.35- and 0.5-mm-diameter computed tomography and magnetic resonance images.
    Tanaka O, Komeda H, Iida T, Tamaki M, Seike K, Kato D, Hirose S, Kawaguchi D, Yokoyama T.
    Radiol Med; 2017 Mar 19; 122(3):204-207. PubMed ID: 27981486
    [Abstract] [Full Text] [Related]

  • 10. MRI-alone radiation therapy planning for prostate cancer: Automatic fiducial marker detection.
    Ghose S, Mitra J, Rivest-Hénault D, Fazlollahi A, Stanwell P, Pichler P, Sun J, Fripp J, Greer PB, Dowling JA.
    Med Phys; 2016 May 19; 43(5):2218. PubMed ID: 27147334
    [Abstract] [Full Text] [Related]

  • 11. Evaluation of an automatic MR-based gold fiducial marker localisation method for MR-only prostate radiotherapy.
    Maspero M, van den Berg CAT, Zijlstra F, Sikkes GG, de Boer HCJ, Meijer GJ, Kerkmeijer LGW, Viergever MA, Lagendijk JJW, Seevinck PR.
    Phys Med Biol; 2017 Oct 03; 62(20):7981-8002. PubMed ID: 28825917
    [Abstract] [Full Text] [Related]

  • 12. Investigation of the clinical inter-observer bias in prostate fiducial marker image registration between CT and MR images.
    Persson E, Emin S, Scherman J, Jamtheim Gustafsson C, Brynolfsson P, Ceberg S, Gunnlaugsson A, Olsson LE.
    Radiat Oncol; 2021 Aug 16; 16(1):150. PubMed ID: 34399806
    [Abstract] [Full Text] [Related]

  • 13. Magnetic resonance imaging for prostate bed radiotherapy planning: An inter- and intra-observer variability study.
    Barkati M, Simard D, Taussky D, Delouya G.
    J Med Imaging Radiat Oncol; 2016 Apr 16; 60(2):255-9. PubMed ID: 26568515
    [Abstract] [Full Text] [Related]

  • 14. Visibility of an iron-containing fiducial marker in magnetic resonance imaging for high-precision external beam prostate radiotherapy.
    Tanaka O, Komeda H, Hirose S, Taniguchi T, Ono K, Matsuo M.
    Asia Pac J Clin Oncol; 2018 Oct 16; 14(5):e405-e411. PubMed ID: 29193796
    [Abstract] [Full Text] [Related]

  • 15. T2 Star-weighted Angiography (SWAN) Allows to Concomitantly Assess the Prostate Contour While Detecting Fiducials Before MR-based Intensity-modulated Radiation Therapy in Prostate Carcinoma.
    Dirajlal PA, Jambon E, Albat-Esquirou A, Galmiche C, Bernhard JC, Grenier N, Haaser T, Cornelis FH.
    Acad Radiol; 2018 Jan 16; 25(1):95-101. PubMed ID: 28844603
    [Abstract] [Full Text] [Related]

  • 16. Geometric discrepancy of image-guided radiation therapy in patients with prostate cancer without implanted fiducial markers using a commercial pseudo-CT generation method.
    Kan H, Eguchi Y, Tsuchiya T, Kondo T, Kitagawa Y, Mekata Y, Fukuma H, Yoshida R, Kasai H, Kunitomo H, Hirose Y, Shibamoto Y.
    Phys Med Biol; 2019 Mar 08; 64(6):06NT01. PubMed ID: 30695772
    [Abstract] [Full Text] [Related]

  • 17. PTV margin definition in hypofractionated IGRT of localized prostate cancer using cone beam CT and orthogonal image pairs with fiducial markers.
    Oehler C, Lang S, Dimmerling P, Bolesch C, Kloeck S, Tini A, Glanzmann C, Najafi Y, Studer G, Zwahlen DR.
    Radiat Oncol; 2014 Nov 11; 9():229. PubMed ID: 25384898
    [Abstract] [Full Text] [Related]

  • 18. Comparison of manual and automatic MR-CT registration for radiotherapy of prostate cancer.
    Korsager AS, Carl J, Riis Østergaard L.
    J Appl Clin Med Phys; 2016 May 08; 17(3):294-303. PubMed ID: 27167285
    [Abstract] [Full Text] [Related]

  • 19. Precision of T2 TSE MRI-CT-image fusions based on gold fiducials and repetitive T2 TSE MRI-MRI-fusions for adaptive IGRT of prostate cancer by using phantom and patient data.
    Wegener D, Zips D, Thorwarth D, Weiß J, Othman AE, Grosse U, Notohamiprodjo M, Nikolaou K, Müller AC.
    Acta Oncol; 2019 Jan 08; 58(1):88-94. PubMed ID: 30264629
    [Abstract] [Full Text] [Related]

  • 20. Quantification of fiducial marker visibility for MRI-only prostate radiotherapy simulation.
    Singhrao K, Ruan D, Fu J, Gao Y, Chee G, Yang Y, King C, Hu P, Kishan AU, Lewis JH.
    Phys Med Biol; 2020 Feb 05; 65(3):035015. PubMed ID: 31881546
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.